| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |